Principal Scientist Biotherapeutics

Johnson & Johnson Johnson & Johnson · Pharma · Leiden, South Holland, Netherlands +2

Principal Scientist Biotherapeutics role at Johnson & Johnson focused on leading global analytical development activities for protein products. Responsibilities include method development, comparability studies, regulatory submissions, and managing cross-functional scientific teams. Requires a Master's degree with 8+ years of experience or a Ph.D. with 3+ years of experience in biopharmaceutical development.

What you'd actually do

  1. Lead analytical development activities across clinical development and/or life cycle management, including but not limited to, CMC development, method replacements, comparability studies, shelf life extensions and specification management.
  2. Accountable for analytical content in global regulatory submission, post approval submissions, and health authority interactions, including audits.
  3. Represent AD on the CMC and VC team and be accountable for all analytical deliverables.
  4. Define and drive analytical strategies aligned with product phase and regulatory expectations, and lead a cross-functional scientific team consisting of members from each of the AD sub-functions.
  5. Effectively communicate project status/overview, resources, budget, risks, and mitigation strategies to senior management.

Skills

Required

  • Master's degree in Analytical Chemistry, Biochemistry, Biological Science, or a related scientific discipline with at least 8 years of experience in biopharmaceutical development
  • Working knowledge of biotherapeutic development and analytical strategy including analytical protein characterization, separation techniques, and biological potency assays

Nice to have

  • Ph.D. in Analytical Chemistry, Biochemistry, Biological Science, or a related scientific discipline with at least 3 years of experience in biopharmaceutical development
  • Experience authoring and reviewing IND and/or BLA/MAA sections and addressing health authority questions

What the JD emphasized

  • biopharmaceutical development
  • analytical protein characterization
  • biological potency assays